NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/11/2022
Voltar para busca
Dado oficial do USPTO
DIZAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
01/11/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35
Data de depósito
29/09/2020
Data de registro
01/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/11/2022
Última transação
01/11/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
27/10/2017
Primeiro uso no comércio
18/11/2019
Código do desenho
3
Tipo de titular
03
Localização do titular
Wuxi City, Jiangsu, CN
Examinador
NEHMER, JASON ROBERT
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "DIZAL" above four Chinese Characters. To the left of the wording is a design of two curved bands.
Titulares e representantes
Titulares
Dizal (Jiangsu) Pharmaceutical Co., Ltd
Representantes
Catherine M.C. Farrelly Frankfurt Kurnit Klein & Selz PC
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Preparations for destroying noxious animals; antiseptics; bacterial culture mediums; bouillons for bacteriological cultures; media for bacteriological cultures; bacterial poisons; balsamic preparations for medical purposes; insecticides; medicinal preparations for the mouth to be applied in the form of capsules; pharmaceutical preparations for treatment of human illnessesanti-tumor treatment; chemico-pharmaceutical preparations for treatment of human illnessesanti-tumor treatment; collyrium; medicines for alleviating constipation; solutions for contact lenses; radiological contrast substances for medical purposes; depuratives for the body; digestives for pharmaceutical purposes; analgesics; drugs for medical purposes for treatment of human illnessesanti-tumor treatment; filled portable medicine casescomprised of pharmaceuticals for treatment of human illnessesanti-tumor treatment; pharmaceutical preparationselixirs for anti-tumor treatment; mineralbath and sodium salts for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; fungicides; gelatine for medical purposesgelatin capsules sold empty; germicides; chewing gum for medical purposes; medicated lozenges for pharmaceutical purposes; cough pastilles for pharmaceutical purposes; rat poison; antibioticsunburn and anti-inflammatory ointments for pharmaceutical purposes; organotherapy preparations; opotherapy preparations; pharmaceutical preparations for skin care; herbal teas for medicinal purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; first-aid boxesfilled; blood plasma; radioactive substances for medical purposes; tonics being pharmaceutical preparations for the treatment of human illnessesanti-tumor treatment; blood for medical purposes; sterilizing preparations; styptic preparations; aluminum acetates for pharmaceutical purposes; acids for pharmaceutical purposes; dietetic foods adapted for medical purposes; biological preparations for medical purposes for treatment of human illnesses; dietetic beverages adapted for medical purposes; crystallized rock sugar for medical purposes; candy for medical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; by-products of the processing of cereals for dietetic or medical purposes; chemical preparations for pharmaceutical purposes for the treatment of human illnessesanti-tumor treatment; medicines for dental purposes; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; diagnostic preparations for medical purposes; medicinal drinks; petroleum jelly for medical purposes; isotopes for medical purposes; dietetic substances of low sugar and salt adapted for medical use; chemical preparations as medicines for medical purposesfor anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; contact lens cleaning preparations; enzymes for medical purposes; enzyme preparations for medical purposes; amino acids for medical purposes; antibiotics; bronchodilating preparations; medicinal hair growth preparations; adjuvants for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; medicated eye-washes; antioxidant pills for medical use; protein dietary supplements; reagent paper for medical purposes; pesticides; diagnostic biomarker reagents for medical purposes; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposesanti-tumor treatment; reagent paper for veterinary purposes; astringents for medical purposes; insecticidal veterinary washes; capsules made of dendrimer-based polymers for medicinal preparations for the mouthfor pharmaceuticals purposes; raw material drugspharmaceuticals for anti-tumor treatment; Chinese medicine nostrum for the treatment of tumors in humans; pharmaceutical blood preparationsa blood clotting aid and delivery system for use in human medicine; rubbing alcohol; agricultural fungicide; eye drops; insect killing preparations in the nature of pesticides; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; candy for pharmaceutical purpose for treatment of the cough; bacteriological research preparationpreparations of reports for anti-tumor treatment for medical purposes; bacterial preparations for medical purposes for researching of human illnesses; medical probiotic supplements; medical diagnosis reagent; vaccine preparations; contact lenses care solution; contact lens disinfectant; biological agents for the treatment of cancer
Classe 35
Publicity consultation and agency services in the field of medicines; provision of goods sales informationsales information about goods for anti-tumor treatment; retail store services featuring pharmaceuticalsanitary preparations and medical supplies; wholesale distributorships featuring pharmaceutical preparationssanitary preparationsmedical supplies; retail store services and wholesale store services featuring pharmaceutical drugs; retail store services and wholesale store services featuring medicinal preparations; retail store services and wholesale store services featuring sanitary preparations; retail store services and wholesale store services featuring medical supplies
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
30/09/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
28/09/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
23/09/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
20/09/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
18/09/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
16/09/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/09/2022
IUAF
USE AMENDMENT FILED
31/08/2022
EISU
TEAS STATEMENT OF USE RECEIVED
31/08/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2022
PUBO
PUBLISHED FOR OPPOSITION
04/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/11/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/10/2021
GNRT
NON-FINAL ACTION E-MAILED
14/10/2021
CNRT
NON-FINAL ACTION WRITTEN
14/10/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/10/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/09/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/09/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/09/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/09/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/09/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/09/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/03/2021
GNFR
FINAL REFUSAL E-MAILED
12/03/2021
CNFR
FINAL REFUSAL WRITTEN
12/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/03/2021
GNRT
NON-FINAL ACTION E-MAILED
01/03/2021
CNRT
NON-FINAL ACTION WRITTEN
01/03/2021
DOCK
ASSIGNED TO EXAMINER
22/02/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
13/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/11/2020
NWAP
NEW APPLICATION ENTERED
02/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DIZAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.